CN1872025A - 一种美容护肤产品、其制备方法 - Google Patents
一种美容护肤产品、其制备方法 Download PDFInfo
- Publication number
- CN1872025A CN1872025A CN 200610002359 CN200610002359A CN1872025A CN 1872025 A CN1872025 A CN 1872025A CN 200610002359 CN200610002359 CN 200610002359 CN 200610002359 A CN200610002359 A CN 200610002359A CN 1872025 A CN1872025 A CN 1872025A
- Authority
- CN
- China
- Prior art keywords
- stem cell
- beauty
- skin care
- care product
- active component
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000002360 preparation method Methods 0.000 title claims description 16
- 238000004519 manufacturing process Methods 0.000 title 1
- 210000000130 stem cell Anatomy 0.000 claims abstract description 114
- 210000004369 blood Anatomy 0.000 claims abstract description 99
- 239000008280 blood Substances 0.000 claims abstract description 99
- 238000000034 method Methods 0.000 claims abstract description 8
- 239000000047 product Substances 0.000 claims description 77
- 230000003796 beauty Effects 0.000 claims description 37
- 239000001963 growth medium Substances 0.000 claims description 23
- 239000006071 cream Substances 0.000 claims description 18
- 239000007788 liquid Substances 0.000 claims description 9
- 108090000379 Fibroblast growth factor 2 Proteins 0.000 claims description 8
- 102100024785 Fibroblast growth factor 2 Human genes 0.000 claims description 8
- 239000000126 substance Substances 0.000 claims description 8
- 230000001815 facial effect Effects 0.000 claims description 7
- 235000015097 nutrients Nutrition 0.000 claims description 7
- 239000000284 extract Substances 0.000 claims description 6
- 235000016709 nutrition Nutrition 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- 239000000839 emulsion Substances 0.000 claims description 5
- 238000002372 labelling Methods 0.000 claims description 5
- 239000000706 filtrate Substances 0.000 claims description 3
- 238000002347 injection Methods 0.000 claims description 3
- 239000007924 injection Substances 0.000 claims description 3
- 238000000108 ultra-filtration Methods 0.000 claims description 3
- 210000000481 breast Anatomy 0.000 claims description 2
- 238000004140 cleaning Methods 0.000 claims description 2
- 239000008278 cosmetic cream Substances 0.000 claims description 2
- 235000012459 muffins Nutrition 0.000 claims description 2
- 238000003672 processing method Methods 0.000 claims description 2
- 239000000344 soap Substances 0.000 claims description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 claims 1
- 210000003491 skin Anatomy 0.000 description 54
- 239000002537 cosmetic Substances 0.000 description 42
- 210000004027 cell Anatomy 0.000 description 33
- 230000000694 effects Effects 0.000 description 30
- 239000000243 solution Substances 0.000 description 20
- 230000012010 growth Effects 0.000 description 17
- 239000000203 mixture Substances 0.000 description 15
- 230000002087 whitening effect Effects 0.000 description 11
- 239000004480 active ingredient Substances 0.000 description 10
- 210000001185 bone marrow Anatomy 0.000 description 10
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 9
- 102000013275 Somatomedins Human genes 0.000 description 9
- 210000004700 fetal blood Anatomy 0.000 description 9
- 238000002156 mixing Methods 0.000 description 9
- 230000003321 amplification Effects 0.000 description 8
- 239000012531 culture fluid Substances 0.000 description 8
- 210000002514 epidermal stem cell Anatomy 0.000 description 8
- 238000011156 evaluation Methods 0.000 description 8
- 230000004060 metabolic process Effects 0.000 description 8
- 238000003199 nucleic acid amplification method Methods 0.000 description 8
- 239000006228 supernatant Substances 0.000 description 8
- 210000000589 cicatrix Anatomy 0.000 description 7
- 210000001671 embryonic stem cell Anatomy 0.000 description 7
- 210000002615 epidermis Anatomy 0.000 description 7
- 210000002950 fibroblast Anatomy 0.000 description 7
- 241000699660 Mus musculus Species 0.000 description 6
- 238000010790 dilution Methods 0.000 description 6
- 239000012895 dilution Substances 0.000 description 6
- 230000003203 everyday effect Effects 0.000 description 6
- 210000004698 lymphocyte Anatomy 0.000 description 6
- 239000002609 medium Substances 0.000 description 6
- 238000011580 nude mouse model Methods 0.000 description 6
- 238000000926 separation method Methods 0.000 description 6
- 230000037303 wrinkles Effects 0.000 description 6
- 238000005119 centrifugation Methods 0.000 description 5
- 239000012530 fluid Substances 0.000 description 5
- 210000002901 mesenchymal stem cell Anatomy 0.000 description 5
- 102000004127 Cytokines Human genes 0.000 description 4
- 108090000695 Cytokines Proteins 0.000 description 4
- 108010019160 Pancreatin Proteins 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 4
- 208000018999 crinkle Diseases 0.000 description 4
- 230000004069 differentiation Effects 0.000 description 4
- 210000003958 hematopoietic stem cell Anatomy 0.000 description 4
- 229940055695 pancreatin Drugs 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 206010002198 Anaphylactic reaction Diseases 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- 102100031573 Hematopoietic progenitor cell antigen CD34 Human genes 0.000 description 3
- 101000777663 Homo sapiens Hematopoietic progenitor cell antigen CD34 Proteins 0.000 description 3
- 230000036783 anaphylactic response Effects 0.000 description 3
- 208000003455 anaphylaxis Diseases 0.000 description 3
- 230000010261 cell growth Effects 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 238000005374 membrane filtration Methods 0.000 description 3
- 238000003825 pressing Methods 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- BELBBZDIHDAJOR-UHFFFAOYSA-N Phenolsulfonephthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2S(=O)(=O)O1 BELBBZDIHDAJOR-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 206010052428 Wound Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 239000012930 cell culture fluid Substances 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 230000019522 cellular metabolic process Effects 0.000 description 2
- 239000002131 composite material Substances 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 238000011010 flushing procedure Methods 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 230000001900 immune effect Effects 0.000 description 2
- 230000033001 locomotion Effects 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 210000001178 neural stem cell Anatomy 0.000 description 2
- 229960003531 phenolsulfonphthalein Drugs 0.000 description 2
- 238000004321 preservation Methods 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 230000008439 repair process Effects 0.000 description 2
- 230000010076 replication Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 210000004927 skin cell Anatomy 0.000 description 2
- DAEPDZWVDSPTHF-UHFFFAOYSA-M sodium pyruvate Chemical compound [Na+].CC(=O)C([O-])=O DAEPDZWVDSPTHF-UHFFFAOYSA-M 0.000 description 2
- 230000017423 tissue regeneration Effects 0.000 description 2
- 238000002054 transplantation Methods 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 2
- 241000086254 Arnica montana Species 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010048768 Dermatosis Diseases 0.000 description 1
- 102000018233 Fibroblast Growth Factor Human genes 0.000 description 1
- 108050007372 Fibroblast Growth Factor Proteins 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000233805 Phoenix Species 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 102000019197 Superoxide Dismutase Human genes 0.000 description 1
- 108010012715 Superoxide dismutase Proteins 0.000 description 1
- 108010017842 Telomerase Proteins 0.000 description 1
- 208000003441 Transfusion reaction Diseases 0.000 description 1
- 210000002718 aborted fetus Anatomy 0.000 description 1
- 230000001464 adherent effect Effects 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 210000004271 bone marrow stromal cell Anatomy 0.000 description 1
- 229910021538 borax Inorganic materials 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 210000005056 cell body Anatomy 0.000 description 1
- 230000024245 cell differentiation Effects 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 239000007765 cera alba Substances 0.000 description 1
- 238000007385 chemical modification Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000019771 cognition Effects 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000010494 dissociation reaction Methods 0.000 description 1
- 230000005593 dissociations Effects 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- -1 fatty acid sodium salt Chemical class 0.000 description 1
- 210000003746 feather Anatomy 0.000 description 1
- 230000004720 fertilization Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 229940126864 fibroblast growth factor Drugs 0.000 description 1
- 150000004675 formic acid derivatives Chemical class 0.000 description 1
- 238000013467 fragmentation Methods 0.000 description 1
- 238000006062 fragmentation reaction Methods 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 239000006481 glucose medium Substances 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 230000003394 haemopoietic effect Effects 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 238000011532 immunohistochemical staining Methods 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 238000013507 mapping Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 210000005155 neural progenitor cell Anatomy 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000003716 rejuvenation Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 230000036559 skin health Effects 0.000 description 1
- 229940054269 sodium pyruvate Drugs 0.000 description 1
- 239000004328 sodium tetraborate Substances 0.000 description 1
- 235000010339 sodium tetraborate Nutrition 0.000 description 1
- 229940084106 spermaceti Drugs 0.000 description 1
- 239000012177 spermaceti Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 238000002525 ultrasonication Methods 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 210000003954 umbilical cord Anatomy 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Images
Landscapes
- Cosmetics (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
实施例 | 干细胞活性成分 | 美容产品 | 维持活性成分的营养物质 | 除皱美白综合效果 |
6 | 0.2wt%实施例2 | 乳液89wt% | 10% | 3.46分 |
7 | 10wt%实施例3 | 针剂70wt% | 16% | 4.76分 |
8 | 30wt%实施例4 | 洗面奶45wt% | 20% | 8.79分 |
9 | 50wt%实施例5 | 按摩膏25% | 20% | 7.32分 |
组别 | 血型 | 平均分 | |||
A | B | O | AB | ||
X | 2.98 | 3.10 | 2.32 | 2.43 | 2.71 |
Y | 8.91 | 9.02 | 8.76 | 8.89 | 8.89 |
Z | 3.12 | 3.35 | 2.43 | 5.76 | 3.67 |
不同血型干细胞活性成分 | 不同血型受试者 | |||
A | B | O | AB | |
A | 8.63 | 3.65 | 4.21 | 3.89 |
B | 4.12 | 8.96 | 3.96 | 4.01 |
O | 4.02 | 3.43 | 9.01 | 4.18 |
AB | 3.45 | 3.12 | 4.76 | 8.75 |
不按血型分型 | 3.43 | 3.21 | 4.06 | 5.35 |
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2006100023598A CN100508948C (zh) | 2005-01-28 | 2006-01-27 | 一种美容护肤产品、其制备方法 |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200510004937 | 2005-01-28 | ||
CN200510004937.7 | 2005-01-28 | ||
CNB2006100023598A CN100508948C (zh) | 2005-01-28 | 2006-01-27 | 一种美容护肤产品、其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1872025A true CN1872025A (zh) | 2006-12-06 |
CN100508948C CN100508948C (zh) | 2009-07-08 |
Family
ID=37482736
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2006100023598A Active CN100508948C (zh) | 2005-01-28 | 2006-01-27 | 一种美容护肤产品、其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100508948C (zh) |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102552099A (zh) * | 2011-12-30 | 2012-07-11 | 王英丽 | 一种用于皮肤美容修复的复合生物制剂及制备方法 |
CN102988200A (zh) * | 2012-12-10 | 2013-03-27 | 北京莱米瑞克科技发展有限公司 | 脂质体养颜护肤品 |
CN103446029A (zh) * | 2012-05-28 | 2013-12-18 | 孙勇 | 一种美容护肤品用脐带胎盘干细胞技术 |
CN104946585A (zh) * | 2015-07-07 | 2015-09-30 | 美天妮(天津)生物科技有限公司 | 一种人间充质干细胞培养液上清的生产方法及冻干方法及应用 |
CN105002133A (zh) * | 2014-04-23 | 2015-10-28 | 宋阳 | 人体脐带血干细胞提取物及其制备方法和应用 |
CN105030631A (zh) * | 2014-12-12 | 2015-11-11 | 黄宗堂 | 一种干细胞面霜及其制备方法 |
CN108456656A (zh) * | 2018-03-26 | 2018-08-28 | 北京贝诗丹生物科技有限公司 | DBMSCs活性物质、制备方法及其在护肤品中的应用 |
CN108542877A (zh) * | 2017-03-23 | 2018-09-18 | 广州资生生物科技有限公司 | 一种皮米级细胞提取物的制备方法 |
WO2019073999A1 (ja) * | 2017-10-13 | 2019-04-18 | マイクロニクス株式会社 | 細胞内液精製システム、細胞内液精製方法、炎症性腸疾患の予防剤、改善剤または治療剤、あるいは、精子活性化剤、もしくは、化粧品成分を製造する製造方法、炎症性腸疾患の予防剤、改善剤または治療剤、および、精子活性化剤の製造方法 |
-
2006
- 2006-01-27 CN CNB2006100023598A patent/CN100508948C/zh active Active
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102552099A (zh) * | 2011-12-30 | 2012-07-11 | 王英丽 | 一种用于皮肤美容修复的复合生物制剂及制备方法 |
CN102552099B (zh) * | 2011-12-30 | 2014-06-18 | 王英丽 | 一种用于皮肤美容修复的复合生物制剂及制备方法 |
CN103446029A (zh) * | 2012-05-28 | 2013-12-18 | 孙勇 | 一种美容护肤品用脐带胎盘干细胞技术 |
CN102988200A (zh) * | 2012-12-10 | 2013-03-27 | 北京莱米瑞克科技发展有限公司 | 脂质体养颜护肤品 |
CN102988200B (zh) * | 2012-12-10 | 2014-09-17 | 北京莱米瑞克科技发展有限公司 | 脂质体养颜护肤品 |
CN105002133A (zh) * | 2014-04-23 | 2015-10-28 | 宋阳 | 人体脐带血干细胞提取物及其制备方法和应用 |
CN105030631A (zh) * | 2014-12-12 | 2015-11-11 | 黄宗堂 | 一种干细胞面霜及其制备方法 |
CN104946585A (zh) * | 2015-07-07 | 2015-09-30 | 美天妮(天津)生物科技有限公司 | 一种人间充质干细胞培养液上清的生产方法及冻干方法及应用 |
CN108542877A (zh) * | 2017-03-23 | 2018-09-18 | 广州资生生物科技有限公司 | 一种皮米级细胞提取物的制备方法 |
WO2019073999A1 (ja) * | 2017-10-13 | 2019-04-18 | マイクロニクス株式会社 | 細胞内液精製システム、細胞内液精製方法、炎症性腸疾患の予防剤、改善剤または治療剤、あるいは、精子活性化剤、もしくは、化粧品成分を製造する製造方法、炎症性腸疾患の予防剤、改善剤または治療剤、および、精子活性化剤の製造方法 |
CN108456656A (zh) * | 2018-03-26 | 2018-08-28 | 北京贝诗丹生物科技有限公司 | DBMSCs活性物质、制备方法及其在护肤品中的应用 |
Also Published As
Publication number | Publication date |
---|---|
CN100508948C (zh) | 2009-07-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11369716B2 (en) | Reparative cell isolation and delivery | |
CN1872025A (zh) | 一种美容护肤产品、其制备方法 | |
CN101748096B (zh) | 亚全能干细胞、其制备方法及其用途 | |
CN106318904B (zh) | 间充质干细胞条件培养基用于美容品领域的用途 | |
US20110217385A1 (en) | Method for extracting mesenchymal stem cell from human or animal embryo and for extracting the secretion product thereof | |
CN104726406B (zh) | 一种诱导牙髓间充质干细胞分化为神经细胞的方法 | |
CN110269833A (zh) | 一种脐带间充质干细胞制剂及其制备方法和应用 | |
CN101461772A (zh) | 用于美容护肤的干细胞分泌因子的制备方法 | |
JP2014520843A (ja) | 臍帯抽出物の製造方法及びその用途 | |
CN1571835A (zh) | 在创伤治疗中可用作生物活性物质的角质细胞 | |
CN110693804A (zh) | 一种含脐带间充质干细胞因子的面膜及其制备方法 | |
CN108753708A (zh) | 一种干细胞活性因子冻干粉的制备方法 | |
CN109735490A (zh) | 一种脂肪干细胞提取方法 | |
CN103393585A (zh) | 一种用于美容保养的成纤维细胞液及其制备方法 | |
CN1778905A (zh) | 一种脂肪间充质干细胞的分离培养方法及其应用 | |
CN101264344B (zh) | 含毛囊人工皮肤的制备方法及由其制备的人工皮肤 | |
RU2320720C2 (ru) | Способ культивирования фибробластов для заместительной терапии | |
CN112716976A (zh) | 含脐带间充质干细胞的纳米复合水凝胶及其制备方法和应用 | |
CN102703380B (zh) | 亚全能干细胞、其制备方法及其用途 | |
CN104818243A (zh) | 一种胎盘源胎儿干细胞的分离方法 | |
CN111040984A (zh) | 脐带间充质干细胞诱导分化形成皮肤成纤维细胞的方法 | |
CN101054572A (zh) | 人脐血干细胞培养及定向分化为多巴胺能神经细胞的方法及得到的多巴胺能神经细胞的应用 | |
CN113018316A (zh) | 多能干细胞来源的间充质干细胞在修复皮肤损伤中的应用 | |
CN112190695A (zh) | 一种用于美容抗衰的干细胞制剂及其制备方法和应用 | |
CN105039239A (zh) | 细胞转化诱导液及其应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: GUANGZHOU YUANSHENG PHARMACEUTICAL TECHNOLOGY CO., Free format text: FORMER OWNER: LI LINGSONG Effective date: 20111017 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 100083 HAIDIAN, BEIJING TO: 510663 GUANGZHOU, GUANGDONG PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20111017 Address after: High tech Industrial Development Zone, Guangzhou City, Guangdong province 510663 Science City skim Springs Road No. 3 D District, D1006, D1007 in 1008, D1009. Patentee after: Curegenix Inc. Address before: 100083 Xueyuan Road 38, Haidian District, Beijing (Peking University stem cell research center) Patentee before: Li Lingsong |